Success of immunomodulators in MS shifts discovery focus

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Success of immunomodulators in MS shifts discovery focus

Post by MSUK » Fri Dec 02, 2011 7:30 am

Success of immunomodulators in MS shifts discovery focus to neuroprotection

Image

With six immunomodulatory agents in late-stage development for relapsing–remitting multiple sclerosis, this area of the therapeutic space has become highly competitive. Could remyelination therapies that provide neuroprotection be the next frontier?

Close on the heels of the approval last year of the first oral disease-modifying drug for multiple sclerosis (MS), Novartis's fingolimod, six more late-stage contenders — including novel oral agents and monoclonal antibodies (mAbs) — are next up. As a result, the landscape for immunomodulatory agents is becoming increasingly crowded.

The latest clinical trial results for these relapsing–remitting MS (RRMS) treatment contenders were presented in October at the joint ECTRIMS–ACTRIMS meeting in Amsterdam. A highlight was data for Biogen Idec's BG-12 (dimethyl fumarate), an orally available small molecule (with a relative molecular mass of <150) that is thought to act in part by modulating the activity of the transcription factors nuclear factor-κB and NRF2, which have important roles in inflammation. Results from the Phase III DEFINE trial of the drug showed that the drug met its primary end point, significantly reducing the proportion of patients who relapsed at 2 years. Top-line data from the CONFIRM trial — which included Teva's injectable immunomodulator glatiramer acetate as an active comparator — were reported days after the meeting and provided similarly positive results.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... pageid/683
MS-UK - http://www.ms-uk.org/

User avatar
HarryZ
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada
Contact:

Re: Success of immunomodulators in MS shifts discovery focus

Post by HarryZ » Fri Dec 02, 2011 8:08 am

Yes, there certainly is a $ucce$$ of immunomodulators in MS medications these days. The immune systems of MS patients are being compromised more and more and the data being given by the producers looks better and better. But didn't these same people tell us with their data that the CRAB drugs were the answer to MS?!

User avatar
scorpions
Family Member
Posts: 74
Joined: Mon Nov 21, 2011 8:40 am

Re: Success of immunomodulators in MS shifts discovery focus

Post by scorpions » Fri Dec 02, 2011 8:40 am

Thanks Squiffy.

User avatar
sou
Family Elder
Posts: 582
Joined: Sat Dec 20, 2008 3:00 pm
Contact:

Re: Success of immunomodulators in MS shifts discovery focus

Post by sou » Fri Dec 02, 2011 11:56 am

If that is a success, I wonder what a failure could be...

User avatar
scorpions
Family Member
Posts: 74
Joined: Mon Nov 21, 2011 8:40 am

Re: Success of immunomodulators in MS shifts discovery focus

Post by scorpions » Sat Dec 03, 2011 10:14 am

Good thing we all have a choice whether to use them or not.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “General Discussion”